<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="157914">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01684293</url>
  </required_header>
  <id_info>
    <org_study_id>1K23DA034883-01</org_study_id>
    <nct_id>NCT01684293</nct_id>
  </id_info>
  <brief_title>Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study</brief_title>
  <official_title>Occupational Therapy-Based Cognitive Rehabilitation of Cocaine Abusers: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study integrates a model of occupational-therapy based cognitive rehabilitation as part
      of a comprehensive treatment plan for cocaine abusers. We hypothesize that cognitive
      impairment and quality of life would improve and that cocaine use would decrease in those
      participants receiving occupational-therapy based cognitive rehabilitation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      occupational-therapy based cognitive rehabilitation as part of a comprehensive treatment
      plan for cocaine abusers
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Improvement in cognitive impairment</measure>
    <time_frame>baseline through 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Global Deficit Score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Mild Cognitive Impairment, So Stated</condition>
  <arm_group>
    <arm_group_label>Cognitive Rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Occupational therapy-based cognitive rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Psychoeducation/games</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Psychoeducation/games</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Occupational therapy-based cognitive rehabilitation</intervention_name>
    <description>Occupational therapy-based cognitive rehabilitation</description>
    <arm_group_label>Cognitive Rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychoeducation/games</intervention_name>
    <description>Psychoeducation/games</description>
    <arm_group_label>Psychoeducation/games</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18-65

          2. Cocaine abuse or dependence [can be active or in remission]. If abuse of &gt;1 drug,
             cocaine must be primary drug of choice.

          3. Mild-to-moderate cognitive impairment, defined as a Global Deficit Score 1-4, based
             on neurocognitive testing

          4. A Veteran at the San Francisco Veterans Affairs Medical Center

        Exclusion Criteria:

          1. Inability to speak, read, write, and understand English

          2. Inadequate hearing or vision

          3. Current dependence on substances other than cocaine, nicotine, or caffeine

          4. A psychiatric disorder that will interfere with study participation or will make
             participation hazardous (e.g., psychosis, suicidal or homicidal ideations, severe
             anxiety)

          5. A depressive disorder classified as severe, defined as a Beck Depression Inventory-II
             score &gt;29

          6. Current diagnosis of a bipolar disorder needing acute inpatient psychiatric
             hospitalization

          7. Currently symptomatic from attention-deficit/hyperactivity disorder (DSM-5 criteria)

          8. Any learning disorder, any type of dementia, any type of delirium, or an amnestic
             disorder due to any general medical condition

          9. American version of the National Adult Reading Test standard score &lt;70

         10. Mini-Mental State Examination score &lt;24

         11. Global Deficit Score 0 or 5

         12. Current use of scheduled (i.e., prescribed) regular (i.e., daily) psychotropics or
             other medicines with a high likelihood of sedation &amp; cognitive impairment (e.g.,
             benzodiazepines, clozapine, anticholinergics)

         13. Currently prescribed stimulants (e.g., methylphenidate) or cognitive enhancers (e.g.,
             donepezil, memantine)

         14. Active medical illnesses - uncontrolled diabetes, uncontrolled hypertension,
             uncontrolled thyroid dysfunction, or uncontrolled B12/folate deficiency; central
             nervous system illness with potential cognitive aspects (Parkinson's, or Huntington's
             dementia); Needing acute medical hospitalization from HIV sequelae, such as
             HIV-related opportunistic infection

         15. Any history of any type of stroke or brain hemorrhage

         16. Any history of traumatic brain injury, intracranial pathology (e.g., tumor), or brain
             surgery

         17. Currently on probation or parole

         18. Concurrent participation in another study that medically/administratively interferes
             with this study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raj K Kalapatapu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raj K Kalapatapu, MD</last_name>
    <phone>415-221-4810</phone>
    <phone_ext>3075</phone_ext>
    <email>rajkumar.kalapatapu@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, San Francisco &amp; San Francisco Veterans Affairs Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raj K Kalapatapu, M.D.</last_name>
      <phone>415-221-4810</phone>
      <phone_ext>3075</phone_ext>
      <email>rajkumar.kalapatapu@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Raj K Kalapatapu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 11, 2013</lastchanged_date>
  <firstreceived_date>September 10, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
